Clinical Trial Update: Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemotherapy in children with recurrent or refractory sarcomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 2 | Status: COMPLETED